Latest news, press releases, and SEC filings for Nektar Therapeutics (NKTR) https://caymanjournal.com/stock/NKTR en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 23:45:50 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 📊 What This Document Is 📰 This filing is an 8-K, which is a required SEC report used by companies to announce major, unscheduled corporate events. Think of it as an urgent "heads up" bulletin to investors. In this case, Nektar Therapeutics is announcing the impressive results from an extended st https://caymanjournal.com/stock/NKTR/sec-filing/0001193125-26-162763 https://caymanjournal.com/stock/NKTR/sec-filing/0001193125-26-162763 Mon, 20 Apr 2026 00:00:00 GMT SEC Filing